Ryan Allway January 18th, 2019 Kelowna, British Columbia–(Newsfile Corp. – January 17, 2019) – Lexaria Nicotine LLC, (OTCQX: LXRP) (CSE: LXX) a wholly owned subsidiary of Lexaria Bioscience Corp. has entered into a definitive agreement with Altria Group Inc. (NYSE: MO) to fund the research & development of Lexaria’s... Read more
Micron Waste Secures Key Patents As It Looks to Cannabis and Beyond
January 18, 2019
Ryan Allway January 18th, 2019 Exclusive, News, Top News Organic waste disposal is a problem facing a wide range of industries, including food services and processing, brewing and spirits, pulp and paper, biological pharmaceuticals, and even the nascent cannabis industry. With growing government regulation of pollutants and increased corporate... Read more
Aleafia Health Completes Strategic Investment in Australia’s CannaPacific Pty Limited
January 18, 2019
Ryan Allway January 18th, 2019 News, Top News Global Expansion Underway with 10% Equity Investment in Licensed Cannabis Cultivator CannaPacific among Australia’s only Federally Licensed Cultivators with projected 108,000 sq. ft. Greenhouse More TORONTO, Jan. 18, 2019 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSXV: ALEF: OTCQX: ALEAF, FRA: ARAH)... Read more
Ryan Allway January 16th, 2019 Uncategorized The cannabis industry experienced significant growth last year, particularly in Canada following the legalization of adult-use cannabis on a federal level. The upcoming legalization of edible products across Canada could open the door to further growth in 2019 and beyond. Health Canada also... Read more
Why Investors Should Be Focusing on Cannabis Edibles
January 16, 2019
Ryan Allway January 16th, 2019 Exclusive, News, Top News Cannabis edibles are rapidly taking market share from flower. While there are many startups targeting the edibles space, investors may want to consider companies that have already established a reputable brand and distribution network. These companies may be better positioned... Read more
FSD Pharma Announces Holdings in Cannara Biotech Inc.
January 11, 2019
Canada NewsWire TORONTO, Jan. 11, 2019 TORONTO, Jan. 11, 2019 /CNW/ – FSD Pharma (“FSD“) announced today that, in connection with the business combination (the “Business Combination“) completed on December 31, 2018 among Cannara Biotech Inc. (formerly, Dunbar Capital Corp.) (the “Issuer“), Cannara Biotech Inc. and 11038427 Canada Inc., FSD... Read more
Exclusive Interview: Lexaria CEO Discusses Progress & Plans at O’Cannabiz 2018
Uncategorized January 8, 2019
Ryan Allway January 8th, 2019 Uncategorized The O’Cannabiz Conference and Expo in Vancouver, Canada last month featured hundreds of cannabis companies from around the world this year—and CFN Media was there to film exclusive interviews with many of the leaders in the space. Lexaria Biosciences Inc. (CSE: LXX) (OTCQX:... Read more
NetworkNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Proprietary Technology Transforms the Way Molecules Enter the Body
January 8, 2019
Biotechnology company Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) revolutionary technology, DehydraTECH, alters the way that fat soluble, plant-derived molecules are absorbed into the body. A recent article further discussing the company reads, “Chemicals or intimidating complex ingredients that require disclosure on food labels are not required additions when using... Read more
CBD: One of the Biggest Skin Care Breakthroughs of the Year
December 31, 2018
HOUSTON, TX / ACCESSWIRE / December 31, 2018 / Multi-billion-dollar industries are being transformed by cannabis. Beverages, alcohol, beer, sports drinks, pharmaceuticals, tobacco, and the $4.2 trillion wellness industry are just a few, as the cannabis boom just gets underway. In fact, the healing properties of marijuana are why... Read more
High Hampton Holdings Corp. Reports the Fourth Quarter 2018 Financial Results and Provides an Operational and Corporate Update
December 28, 2018
TORONTO, Dec. 28, 2018 CSE: HCOTC: HHPHFFSE: 0HCN TORONTO, Dec. 28, 2018 /CNW/ – High Hampton Holdings Corp. (CSE: HC) (FSE: 0HCN) (“High Hampton” or the “Company”) today announced that it has filed its Consolidated Audited Financial Statements for the year ended August 31, 2018. The Consolidated Financial Statements... Read more
